Insider filing · KALV

VHCP Management III, LLC bought $622K of KalVista Pharmaceuticals (KALV)

Executed Jan 30 2025, disclosed Feb 3 2025, 4 days later.

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

VL VHCP Management III, LLC 10% owner profile →

VHCP Management III, LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in KALV. Across 1 priced purchase filing, the average 21-session return was +6.9% from execution and +13.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of ORKA (122,308 sh across 4 lots, as filed), executed Feb 11 2025.

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→